These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


463 related items for PubMed ID: 28089138

  • 21. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
    Karaaslan A, Soysal A, Altinkanat Gelmez G, Kepenekli Kadayifci E, Söyletir G, Bakir M.
    J Hosp Infect; 2016 Jan; 92(1):67-72. PubMed ID: 26601601
    [Abstract] [Full Text] [Related]

  • 22. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC, Huang SS, Lee CW, Fung CP, Lee N, Shieh WB, Siu LK.
    BMC Infect Dis; 2007 Jul 17; 7():79. PubMed ID: 17640342
    [Abstract] [Full Text] [Related]

  • 23. [Characteristics of epidemiology and antimicrobial resistance of gram-negative bacterial bloodstream infections in children].
    Dong L, Zhang XY, Li CC, Li Z, Xia YQ.
    Zhonghua Er Ke Za Zhi; 2017 Sep 02; 55(9):683-688. PubMed ID: 28881515
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinical experiences of bacteremia caused by metallo-beta-lactamase-producing gram-negative organisms.
    Lee NY, Yan JJ, Lee HC, Liu KH, Huang ST, Ko WC.
    J Microbiol Immunol Infect; 2004 Dec 02; 37(6):343-9. PubMed ID: 15599466
    [Abstract] [Full Text] [Related]

  • 28. Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison.
    Lai CC, Shi ZY, Chen YH, Wang FD.
    J Microbiol Immunol Infect; 2016 Feb 02; 49(1):74-82. PubMed ID: 26586483
    [Abstract] [Full Text] [Related]

  • 29. A Decision Tree Using Patient Characteristics to Predict Resistance to Commonly Used Broad-Spectrum Antibiotics in Children With Gram-Negative Bloodstream Infections.
    Sick-Samuels AC, Goodman KE, Rapsinski G, Colantouni E, Milstone AM, Nowalk AJ, Tamma PD.
    J Pediatric Infect Dis Soc; 2020 Apr 30; 9(2):142-149. PubMed ID: 30690525
    [Abstract] [Full Text] [Related]

  • 30. Bloodstream infections caused by multidrug-resistant gram-negative bacteria: epidemiological, clinical and microbiological features.
    Leal HF, Azevedo J, Silva GEO, Amorim AML, de Roma LRC, Arraes ACP, Gouveia EL, Reis MG, Mendes AV, de Oliveira Silva M, Barberino MG, Martins IS, Reis JN.
    BMC Infect Dis; 2019 Jul 11; 19(1):609. PubMed ID: 31296179
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical and Microbiological Outcomes in Obese Patients Receiving Colistin for Carbapenem-Resistant Gram-Negative Bloodstream Infection.
    Lam SW, Athans V.
    Antimicrob Agents Chemother; 2019 Sep 11; 63(9):. PubMed ID: 31235624
    [Abstract] [Full Text] [Related]

  • 33. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals.
    Papst L, Beović B, Pulcini C, Durante-Mangoni E, Rodríguez-Baño J, Kaye KS, Daikos GL, Raka L, Paul M, ESGAP, ESGBIS, ESGIE and the CRGNB treatment survey study group.
    Clin Microbiol Infect; 2018 Oct 11; 24(10):1070-1076. PubMed ID: 29410094
    [Abstract] [Full Text] [Related]

  • 34. Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea.
    Kim T, Chong YP, Park SY, Jeon MH, Choo EJ, Chung JW, Lee HK, Moon C, Kim DM, Peck KR, Kim YS.
    Diagn Microbiol Infect Dis; 2014 Apr 11; 78(4):457-61. PubMed ID: 24462178
    [Abstract] [Full Text] [Related]

  • 35. High excess costs of infections caused by carbapenem-resistant Gram-negative bacilli in an endemic region.
    Vargas-Alzate CA, Higuita-Gutiérrez LF, López-López L, Cienfuegos-Gallet AV, Jiménez Quiceno JN.
    Int J Antimicrob Agents; 2018 Apr 11; 51(4):601-607. PubMed ID: 29277527
    [Abstract] [Full Text] [Related]

  • 36. Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay.
    Sostarich AM, Zolldann D, Haefner H, Luetticken R, Schulze-Roebecke R, Lemmen SW.
    Infection; 2008 Feb 11; 36(1):31-5. PubMed ID: 18231721
    [Abstract] [Full Text] [Related]

  • 37. Antibiotic resistance. Nosocomial gram-negative infection.
    Gransden WR.
    J Med Microbiol; 1997 Jun 11; 46(6):436-9. PubMed ID: 9379467
    [No Abstract] [Full Text] [Related]

  • 38. Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study.
    Kiratisin P, Chongthaleong A, Tan TY, Lagamayo E, Roberts S, Garcia J, Davies T.
    Int J Antimicrob Agents; 2012 Apr 11; 39(4):311-6. PubMed ID: 22386743
    [Abstract] [Full Text] [Related]

  • 39. Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit.
    Blot S, Depuydt P, Vogelaers D, Decruyenaere J, De Waele J, Hoste E, Peleman R, Claeys G, Verschraegen G, Colardyn F, Vandewoude K.
    Infect Control Hosp Epidemiol; 2005 Jun 11; 26(6):575-9. PubMed ID: 16018434
    [Abstract] [Full Text] [Related]

  • 40. Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection.
    Qu J, Feng C, Li H, Lv X.
    Int J Antimicrob Agents; 2021 Mar 11; 57(3):106284. PubMed ID: 33484833
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 24.